Meeder Asset Management Inc Bio Xcel Therapeutics, Inc. Transaction History

Meeder Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 09, 2021	SELL	$42.46 - $56.58 $117,996 - $157,235	-2,779 Closed	0 $0
Q3 2020 Nov 02, 2020	BUY	$37.44 - $64.63 $30,176 - $52,091	806 Added 40.85%	2,779 $121,000
Q2 2020 Aug 11, 2020	BUY	$17.62 - $58.71 $27,117 - $90,354	1,539 Added 354.61%	1,973 $104,000
Q1 2020 May 15, 2020	BUY	$12.26 - $41.14 $4,646 - $15,592	379 Added 689.09%	434 $8,000
Q4 2019 Feb 13, 2020	SELL	$4.05 - $14.61 $3,009 - $10,855	-743 Reduced 93.11%	55 $1,000
Q3 2019 Oct 17, 2019	BUY	$7.04 - $11.77 $5,617 - $9,392	798 New	798 $5,000

3.13M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $9.53M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.